Spore.Bio Secures $23M Series A to Revolutionize Microbiology Testing

Spore.Bio, a pioneering company in microbiology testing, has raised $23 million in a Series A funding round led by Localglobe. Known for its light-powered microbiology testing, the company is revolutionizing safety across various industries by delivering rapid results that can save lives. Their partnership with the Pasteur Institute and acquisition of a local competitor enhance Spore.Bio’s credibility and reach. The company is already set to introduce their groundbreaking technology in over 200 factories. The funding will help them further their mission to improve food safety and public health. The team at Spore.Bio, including founders Amine Raji, Maxime Mistretta, and Mohamed Tazi, are set to make a significant impact, underlined by their partnerships with influential entities within the industry. The addition of Raffi, Maud, and team Singular stands testament to the collective ambition to make strides in microbiology, benefiting Europe and the global community, particularly in France, known for its leading microbiology expertise.